JP2018537076A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018537076A5 JP2018537076A5 JP2018520493A JP2018520493A JP2018537076A5 JP 2018537076 A5 JP2018537076 A5 JP 2018537076A5 JP 2018520493 A JP2018520493 A JP 2018520493A JP 2018520493 A JP2018520493 A JP 2018520493A JP 2018537076 A5 JP2018537076 A5 JP 2018537076A5
- Authority
- JP
- Japan
- Prior art keywords
- acid sequence
- nucleic acid
- isolated nucleic
- catalytic
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562245978P | 2015-10-23 | 2015-10-23 | |
| US62/245,978 | 2015-10-23 | ||
| US201662382691P | 2016-09-01 | 2016-09-01 | |
| US62/382,691 | 2016-09-01 | ||
| PCT/US2016/058429 WO2017070654A1 (en) | 2015-10-23 | 2016-10-24 | Programmable universal cell receptors and methods of using the same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2018537076A JP2018537076A (ja) | 2018-12-20 |
| JP2018537076A5 true JP2018537076A5 (https=) | 2019-09-19 |
Family
ID=58558187
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018520493A Pending JP2018537076A (ja) | 2015-10-23 | 2016-10-24 | プログラム可能な普遍的細胞受容体およびその使用法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20170112878A1 (https=) |
| EP (1) | EP3365016A4 (https=) |
| JP (1) | JP2018537076A (https=) |
| KR (1) | KR20180091820A (https=) |
| CN (1) | CN108883170A (https=) |
| AU (1) | AU2016341321A1 (https=) |
| CA (1) | CA3002774A1 (https=) |
| EA (1) | EA201890941A1 (https=) |
| TW (1) | TW201726914A (https=) |
| UY (1) | UY36961A (https=) |
| WO (1) | WO2017070654A1 (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2018537076A (ja) * | 2015-10-23 | 2018-12-20 | ソレント・セラピューティクス・インコーポレイテッドＳｏｒｒｅｎｔｏ Ｔｈｅｒａｐｅｕｔｉｃｓ， Ｉｎｃ． | プログラム可能な普遍的細胞受容体およびその使用法 |
| EP3448874A4 (en) | 2016-04-29 | 2020-04-22 | Voyager Therapeutics, Inc. | COMPOSITIONS FOR TREATING A DISEASE |
| US11299751B2 (en) | 2016-04-29 | 2022-04-12 | Voyager Therapeutics, Inc. | Compositions for the treatment of disease |
| US20230159611A1 (en) * | 2017-07-03 | 2023-05-25 | Yale University | Small molecule adapter regulated, target specific chimeric antigen receptor bearing t cells (smart cars) |
| CA3080109A1 (en) | 2017-11-03 | 2019-05-09 | Sorrento Therapeutics, Inc. | Cd38-directed chimeric antigen receptor constructs |
| AU2019231315A1 (en) * | 2018-03-09 | 2020-09-17 | Vivasor, Inc. | Dimeric antigen receptors (DAR) |
| KR20220087519A (ko) * | 2019-10-23 | 2022-06-24 | 유니버시티 오브 플로리다 리서치 파운데이션, 인코포레이티드 | 촉매 항체 38c2를 위한 신규 접합 화학 |
| EP4114415A1 (en) * | 2020-03-06 | 2023-01-11 | Sorrento Therapeutics, Inc. | Innate immunity killer cells targeting psma positive tumor cells |
| CN116601174A (zh) * | 2020-10-12 | 2023-08-15 | 索伦托药业有限公司 | Cd19定向的嵌合抗原受体构建体 |
| KR102618718B1 (ko) * | 2021-01-11 | 2023-12-29 | 주식회사 유틸렉스 | 항-4-1bb 항체 및 pd-1 단백질 또는 이의 단편을 포함하는 이중특이적 에피토프 결합 단백질 및 이의 용도 |
| EP4326292A4 (en) * | 2021-04-23 | 2025-03-26 | Vivasor, Inc. | Dimeric antigen receptors (dars) that bind gd2 |
| US20250186494A1 (en) * | 2022-02-10 | 2025-06-12 | The Scripps Research Institute | Car-t therapies targeted via covalently bonded adapters |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6268488B1 (en) * | 1999-05-25 | 2001-07-31 | Barbas, Iii Carlos F. | Prodrug activation using catalytic antibodies |
| US20060235201A1 (en) * | 2003-02-06 | 2006-10-19 | Roman Kischel | Enduring T cell response |
| PL2187965T3 (pl) * | 2007-08-17 | 2020-05-18 | Purdue Research Foundation | Koniugaty wiążący psma ligand-łącznik i sposoby ich zastosowania |
| CA2776143A1 (en) * | 2009-10-01 | 2011-04-07 | The United States Of America, As Represented By The Secretary, Departmen T Of Health And Human Services | Anti-vascular endothelial growth factor receptor-2 chimeric antigen receptors and use of same for the treatment of cancer |
| RU2012157167A (ru) * | 2010-07-12 | 2014-08-20 | КовЭкс Текнолоджиз Айэлэнд Лимитед | Полифункциональные антительные конъюгаты |
| PH12013501201A1 (en) * | 2010-12-09 | 2013-07-29 | Univ Pennsylvania | Use of chimeric antigen receptor-modified t cells to treat cancer |
| CA2832540C (en) * | 2011-04-08 | 2020-09-15 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Anti-epidermal growth factor receptor variant iii chimeric antigen receptors and use of same for the treatment of cancer |
| WO2013044225A1 (en) * | 2011-09-22 | 2013-03-28 | The Trustees Of The University Of Pennsylvania | A universal immune receptor expressed by t cells for the targeting of diverse and multiple antigens |
| US10851178B2 (en) * | 2011-10-10 | 2020-12-01 | Xencor, Inc. | Heterodimeric human IgG1 polypeptides with isoelectric point modifications |
| JP2018537076A (ja) * | 2015-10-23 | 2018-12-20 | ソレント・セラピューティクス・インコーポレイテッドＳｏｒｒｅｎｔｏ Ｔｈｅｒａｐｅｕｔｉｃｓ， Ｉｎｃ． | プログラム可能な普遍的細胞受容体およびその使用法 |
-
2016
- 2016-10-24 JP JP2018520493A patent/JP2018537076A/ja active Pending
- 2016-10-24 AU AU2016341321A patent/AU2016341321A1/en not_active Abandoned
- 2016-10-24 UY UY0001036961A patent/UY36961A/es not_active Application Discontinuation
- 2016-10-24 WO PCT/US2016/058429 patent/WO2017070654A1/en not_active Ceased
- 2016-10-24 EA EA201890941A patent/EA201890941A1/ru unknown
- 2016-10-24 CA CA3002774A patent/CA3002774A1/en not_active Abandoned
- 2016-10-24 EP EP16858424.1A patent/EP3365016A4/en not_active Withdrawn
- 2016-10-24 KR KR1020187014623A patent/KR20180091820A/ko not_active Withdrawn
- 2016-10-24 US US15/333,115 patent/US20170112878A1/en not_active Abandoned
- 2016-10-24 CN CN201680076271.2A patent/CN108883170A/zh active Pending
- 2016-10-24 TW TW105134363A patent/TW201726914A/zh unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018537076A5 (https=) | ||
| JP7291196B2 (ja) | 抗ヒトパピローマウイルス１６ ｅ７ ｔ細胞受容体 | |
| JP6909844B2 (ja) | 細胞 | |
| JP7303314B2 (ja) | Ｇｐｒｃ５ｄキメラ抗原受容体及びそれを発現する細胞 | |
| JP7179030B2 (ja) | Ｒｏｒ１ ｃａｒ ｔ細胞 | |
| JP2022109915A (ja) | Ｃｄ８０バリアント免疫調節タンパク質およびその使用 | |
| JP7313746B2 (ja) | キメラ抗原受容体及び当該キメラ抗原受容体を発現する免疫エフェクター細胞 | |
| JP2015513920A5 (https=) | ||
| JP7584453B2 (ja) | Ｔａｃｉを標的とする抗体及びキメラ抗原受容体 | |
| EP3773630A1 (en) | Bcma-car-t cells | |
| CN114401989A (zh) | 靶向bcma的抗体及嵌合抗原受体 | |
| CN110461363B (zh) | 靶向cd37的嵌合抗原受体 | |
| JP2022513460A5 (https=) | ||
| CN110616191A (zh) | 共刺激配体联合的car t疗法 | |
| JP2022527081A5 (https=) | ||
| JP2020532969A5 (https=) | ||
| AU2025204510A9 (en) | Car library and scFv manufacturing method | |
| JP2023549441A5 (https=) | ||
| WO2024210072A1 (ja) | キメラタンパク質、核酸、ベクター、ｔ細胞又はｎｋ細胞、医薬組成物、組み合わせ物、組み合わせ医薬、及び標的抗原結合タンパク質 | |
| CN118541394A (zh) | 分泌team的抗间皮素car t细胞及其使用方法 | |
| Angyal et al. | Possible therapeutic applications of single-chain antibodies in systemic autoimmune diseases |